| 1 |
32986054 | Interaction of fibrinogen-magnetic nanoparticle bioconjugates with integrin reconstituted into artificial membranes. | 2020 Oct 14 |
2 |
| 2 |
30445261 | Inhibition of catalytic activity of fibrinogen-stabilized gold nanoparticles via thrombin-induced inclusion of nanoparticle into fibrin: Application for thrombin sensing with more than 104-fold selectivity. | 2019 Mar 5 |
1 |
| 3 |
31337804 | Citrate anion improves chronic dialysis efficacy, reduces systemic inflammation and prevents Chemerin-mediated microvascular injury. | 2019 Jul 23 |
1 |
| 4 |
29085987 | Short-chained oligo(ethylene oxide)-functionalized gold nanoparticles: realization of significant protein resistance. | 2018 Jan |
1 |
| 5 |
29973023 | [Effects of application of citrate anticoagulation in bedside continuous blood purification of severe burn patients with sepsis]. | 2018 Feb 20 |
1 |
| 6 |
27102694 | The effect of continuous elimination methods on the hemostatic profile of a cardiac surgery patient monitored using thromboelastography. | 2016 May 16 |
1 |
| 7 |
19513421 | Oxidative modification of fibrinogen inhibits its transformation into fibrin under the effect of thrombin. | 2009 Feb |
1 |
| 8 |
18558494 | A new feasible method for fibrinogen purification based on the affinity of Staphylococcus aureus clumping factor A to fibrinogen. | 2008 Sep |
1 |
| 9 |
18605954 | Can both EDTA and citrate plasma samples be used in measurements of fibrinogen and C-reactive protein concentrations? | 2008 |
5 |
| 10 |
17408294 | Stability and state of aggregation of aqueous fibrinogen and dipalmitoylphosphatidylcholine lipid vesicles. | 2007 May 8 |
2 |
| 11 |
17015275 | Human blood plasma advanced oxidation protein products (AOPP) correlates with fibrinogen levels. | 2006 Sep |
1 |
| 12 |
11341513 | Absence of fibrinogen in afibrinogenemia results in large but loosely packed thrombi under flow conditions. | 2001 Apr |
1 |
| 13 |
7526817 | The measurement of fibrinogen in population-based research. Studies on instrumentation and methodology. | 1994 Nov |
1 |
| 14 |
1333636 | Influence of dry heat treatment and anticoagulant on coupling of fibrinogen and fibronectin to von Willebrand factor in normal plasma. | 1992 Nov |
1 |
| 15 |
2455358 | Monitoring of hemostasis parameters during coronary thrombolysis with recombinant tissue-type plasminogen activator. | 1988 Apr 8 |
2 |
| 16 |
3343546 | Evidence of increased association of fibrinogen with platelets caused by sodium citrate. | 1988 Mar |
15 |
| 17 |
3095944 | Pharmacokinetics and effects on fibrinolytic and coagulation parameters of two doses of recombinant tissue-type plasminogen activator in healthy volunteers. | 1986 Aug 20 |
1 |
| 18 |
3738860 | Soluble fibrinogen derivatives generated by thrombin: affinity for elastin. | 1986 Jul 15 |
1 |
| 19 |
3983897 | Purification and characterization of 3 fibrinogens with different molecular weights obtained from normal human plasma. | 1985 Jan 1 |
1 |
| 20 |
6729777 | The role of sodium citrate in the dysfibrinogenaemia of liver disease. | 1984 May 1 |
3 |
| 21 |
6824684 | Inhibition of fibrin polymerization by fragment d is affected by calcium, Gly-Pro-Arg and Gly-His-Arg. | 1983 Jan 12 |
1 |
| 22 |
6294903 | Some chemical aspects of labeling human fibrinogen with 99m-technetium. | 1982 Nov 1 |
1 |
| 23 |
6458117 | Human fibrinogen binds EDTA and citrate. | 1981 Jun 1-25 |
1 |
| 24 |
64398 | [Micromethod for the determination of heat fibrinogen]. | 1976 |
1 |